APPLICATION
ANDA074046
TYPE
ANDA
ORIGINAL APPROVAL
1993-10-19
LATEST ACTION
2007-05-07
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
ALPRAZOLAMDiscontinued
ALPRAZOLAM 0.25MG · TABLET · ORAL
ALPRAZOLAMDiscontinued
ALPRAZOLAM 2MG · TABLET · ORAL
ALPRAZOLAMDiscontinued
ALPRAZOLAM 0.5MG · TABLET · ORAL
ALPRAZOLAMDiscontinued
ALPRAZOLAM 1MG · TABLET · ORAL
Approval history
2007-05-07Labeling · Supplement 6AP
2001-11-19Labeling · Supplement 4AP
2000-12-22Labeling · Supplement 3AP
1997-05-07Manufacturing (CMC) · Supplement 1AP
1997-05-07Labeling · Supplement 2AP
1993-10-19OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.